Urogenital Diseases: News and Research on Urogenital Neoplasms

MeSH tree: C12.050.351.937

FDA approves Inlexzo for bladder cancer

The U.S. Food and Drug Administration has approved Inlexzo (gemcitabine intravesical system) for the treatment of patients with certain types of bladder cancer.

Urine test can assess risk of kidney cancer recurrence

A simple urine test that can assess the risk of kidney cancer recurrence at an early stage could spare patients from frequent X-ray examinations and thus reduce the associated radiation, anxiety and costs.

page 13 from 40